Niven Ralph's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Nov 27, 2023
- Accession no.
- 0001415889-23-015508
- Filed
- Nov 27, 2023
- Trade date
- Nov 22, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 5 derivative transactions. Open-market sales total $207.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Niven RalphCIK 0001168060 | Officer (CHIEF SCIENTIFIC OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 | Common Stock | MOption exerciseAcquired | +4,200 | $1.74 | +$7,308 | 5,809 | Direct | |
| Nov 22, 2023 | Common Stock | MOption exerciseAcquired | +9,600 | $2.14 | +$20,544 | 15,409 | Direct | |
| Nov 22, 2023 | Common Stock | SSaleDisposed | −13,800 | $15.00 | −$207,000 | 1,609 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 | Common Stock | MOption exerciseDisposed | −2,700 | $0.00 | $0 | 16,008 | Direct | |
| Nov 22, 2023 | Common Stock | MOption exerciseDisposed | −1,500 | $0.00 | $0 | 10,588 | Direct | |
| Nov 22, 2023 | Common Stock | MOption exerciseDisposed | −1,500 | $0.00 | $0 | 12,394 | Direct | |
| Nov 22, 2023 | Common Stock | MOption exerciseDisposed | −3,600 | $0.00 | $0 | 38,508 | Direct | |
| Nov 22, 2023 | Common Stock | MOption exerciseDisposed | −4,500 | $0.00 | $0 | 46,232 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.